Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wednesday, October 3, 2012 - 11:20am
tags:
Exelixis, Roche, GSK, GDC-0973, MEK inhibitor, melanoma
Reconsidering Zalicus And Antares In Light Of Shakeups
Seeking Alpha
Wednesday, October 3, 2012 - 10:56am
tags:
Zalicus, Antares Pharma, Acadia, Novartis, Pfizer, Sanofi
Neurocrine's VMAT-2 Enters Phase IIb
Seeking Alpha
Wednesday, October 3, 2012 - 10:52am
tags:
Neurocrine, Abbott Labs, tardive dyskinesia, NBI-98854, VMAT-2 inhibitor
U.S. judge accepts Abbott misbranding settlement
Reuters
Wednesday, October 3, 2012 - 10:51am
tags:
Abbott Labs, settlements, misbranding, Depakote
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wednesday, October 3, 2012 - 10:50am
tags:
patents, Bristol-Myers Squibb, Amylin, AstraZeneca, Novo Nordisk, Eli Lilly, Merck
Mylan Sues FDA for Approval of Generic Version of Diovan
Bloomberg
Wednesday, October 3, 2012 - 10:48am
tags:
FDA, Mylan, Diovan, generics, Ranbaxy, Novartis
Antares Pharma says it will sell stock to raise research funds; gets $750K payment from Pfizer
Yahoo/AP
Wednesday, October 3, 2012 - 10:47am
tags:
Pfizer, Antares Pharma, stock offering, Vibex QST gel
IPO Preview: Regulus Therapeutics
Seeking Alpha
Wednesday, October 3, 2012 - 10:45am
tags:
IPOs, Regulus, AstraZeneca
AstraZeneca Will Rise Again
Seeking Alpha
Wednesday, October 3, 2012 - 10:44am
tags:
AstraZeneca
Lundbeck, Takeda seek U.S. approval for antidepressant
Chicago Tribune, IL
Tuesday, October 2, 2012 - 12:17pm
tags:
Takeda, Lundbeck, antidepressants, vortioxetine
Abbott CEO: Gonzalez Resume Was An Error
Pharmalot
Tuesday, October 2, 2012 - 12:16pm
tags:
Richard Gonzalez, Abbott Labs, AbbVie
POZEN patents upheld in Treximet patent litigation appeal
The Fly on the Wall
Tuesday, October 2, 2012 - 12:13pm
tags:
Pozen, patents, Treximet, generics
Lessons From Biotech's Best Third Quarter Stocks
TheStreet.com
Tuesday, October 2, 2012 - 11:59am
tags:
Celsion, XenoPort, Peregrine Pharmaceuticals, Sunesis, Opexa, StemCells, Catalyst Pharmaceutical Partners, Hemispherx, Sarepta, Savient
Roche declines comment on report of Illumina bid, Bloomberg reports
Yahoo/Fly on the Wall
Tuesday, October 2, 2012 - 11:57am
tags:
Roche, Illumina, M&A
Illumina Rises On Unusually High Volume
TheStreet.com
Tuesday, October 2, 2012 - 11:56am
tags:
Illumina
Questcor: What's Really Changed?
Seeking Alpha
Tuesday, October 2, 2012 - 11:55am
tags:
Questcor, earnings
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tuesday, October 2, 2012 - 11:25am
tags:
Arqule, lung cancer, Daiichi Sankyo, tivantinib, non-small cell lung cancer
3 Giant Leaps for MannKind
Motley Fool
Tuesday, October 2, 2012 - 10:47am
tags:
MannKind, Afrezza
Pfizer, Novartis And Northwest Biotherapeutics In A Race For IVF Inspired Cancer Cure
Seeking Alpha
Tuesday, October 2, 2012 - 10:45am
tags:
Pfizer, Novartis, Northwest Biotherapeutics, In Vitro Fertilization, cancer
Healthcare Business Review: GenVec’s Conference Success, Neurocrine Begins Trials
Wall St. Cheat Sheet
Tuesday, October 2, 2012 - 10:30am
tags:
GenVec, Neurocrine, NBI-98854

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.